Discover GAP-PS technology for your peptide therapeutics
GAP-PS is an emerging synthesis method that could provide a sustainable and cost-effective solution to what is fast becoming one of the major therapeutic supply challenges of our era.
Our GAP-PS technology (Group Assisted Purification Peptide Synthesis) tackles the traditional challenges of peptide manufacturing (namely reducing consumption of expensive raw material and reducing hazardous waste) to make complex synthetic peptide manufacturing more easily scalable, economical, and sustainable for large-scale commercial production.
Get in touch to learn more about our proof-of-concept study for peptide therapeutics.
Want to learn more? Download our exclusive whitepaper here.
Register your interest in the technology
Join us at Tides USA for our talk: Feasibility of GAP-PS Technology for GLP-1 Peptide Synthesis
Spotlight Presentation Luncheon 1: Monday, 19 May 2025 at 12:45pm - 1:15pm
Discover more about our GAP-PS with Cole Seifert, PhD, Research & Technology Specialist, and its potential to deliver improvements in the peptide manufacturing process.
In this talk we will cover...
GAP Peptide Synthesis Technology
- Principles of GAP-PS and its application in synthesis of GLP-1 peptides, using Semaglutide as a case study
Key Benefits and Industry Impact
- Assess how GAP-PS improves cost efficiency, sustainability, safety, and scalability in peptide production
Scale-Up Potential
- Understand GAP-PS’s readiness for multi-kilogram production and its role in addressing challenges in the growing GLP-1 sector